Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study

Cord blood transplantation (CBT) is an effective option for treating hematological malignancies, but graft failure (GF) remains the primary cause of therapy failure. Thus, based on myeloablative conditioning (MAC) of busulfan with cyclophosphamide (Bu/Cy) or total body irradiation with Cy (TBI/Cy),...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Cancer
Prif Awduron: Sun, Zimin, Liu, Huilan, Luo, Chenhui, Geng, Liangquan, Zheng, Changcheng, Tang, Baolin, Zhu, Xiaoyu, Tong, Juan, Wang, Xingbing, Ding, Kaiyang, Wan, Xiang, Zhang, Lei, Yao, Wen, Song, Kaiding, Zhang, Xuhan, Wu, Yue, Yang, Huizhi, Han, Yongsheng, Liu, Xin, Zhu, Weibo, Wu, Jingsheng, Wang, Zuyi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2018
Pynciau:
Cancer Therapy and Prevention
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033117/
https://ncbi.nlm.nih.gov/pubmed/29473150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31339
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg